Related Experiment Video
Updated: Aug 13, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization
Tiina Sepp1, Jane C Khan, Deborah A Thurlby
1Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
Insights
The complement factor H (CFH) Y402H gene variant is linked to age-related macular degeneration (AMD) in the UK. This genetic risk factor affects both geographic atrophy and choroidal neovascularization, with smoking potentially increasing risk in carriers.
Area of Science:
- Ophthalmology
- Genetics
- Epidemiology
Background:
- Age-related macular degeneration (AMD) is a leading cause of vision loss.
- The complement factor H (CFH) gene Y402H polymorphism (1277T-->C) is a known risk factor for AMD.
- Understanding genetic predispositions and environmental interactions is crucial for AMD management.
Purpose of the Study:
- To confirm the association between the CFH Y402H polymorphism and AMD in a United Kingdom population.
- To investigate if this association differs between geographic atrophy (GA) and choroidal neovascularization (CNV) subtypes of AMD.
- To explore potential interactions between the CFH Y402H polymorphism and smoking status in AMD development.
Main Methods:
- A case-control study involving 443 AMD cases and 262 control subjects (spouses).
- Data collection included health and lifestyle questionnaires, ophthalmic assessments with fundus photography, and genotyping.
- Statistical analyses were performed to compare allele and genotype frequencies and calculate odds ratios.
Main Results:
- The C allele and CC genotype of the CFH Y402H polymorphism were significantly more frequent in AMD cases than controls.
- Odds ratios for AMD were 3.1 (CT genotype) and 6.3 (CC genotype) compared to the TT genotype.
- The association was consistent across GA and CNV subtypes and in smokers and non-smokers, though heavier smokers with the CC genotype showed increased risk.
Conclusions:
- The CFH Y402H gene variant is strongly associated with both geographic atrophy and choroidal neovascularization in the UK population.
- This genetic association with AMD is present in both smokers and non-smokers.
- Individuals with the CC genotype who are heavier smokers may face a particularly elevated risk of developing AMD.
Purpose:
The complement factor H (CFH) gene polymorphism Y402H (1277T-->C) has been associated with susceptibility to age-related macular degeneration (AMD). The purpose of this study was to confirm this association in a U.K. population, to determine whether the association holds for both geographic atrophy (GA) and choroidal neovascularization (CNV), and to investigate interactions with smoking.
Methods:
A case-control study was undertaken in 443 cases of AMD, with 262 spouses as control subjects. All subjects completed a health and lifestyle questionnaire, had an ophthalmic assessment with fundus photography, and were genotyped.
Results:
The frequencies of the C allele and CC genotype were significantly higher in cases than in controls. In comparison to the TT genotype, the odds ratios for AMD associated with the CT and CC genotypes were 3.1 (CI 2.0-4.6) and 6.3 (CI 3.8-10.4), respectively. The results were similar in subgroup analyses confined to cases with GA or CNV. The findings were also similar for subgroup analyses restricted to subjects who had never smoked, moderate smokers, or heavier smokers (>20 pack years of smoking). Heavier smokers with the CC genotype may be particularly at risk. The frequency of the CC genotype did not differ significantly between cases with and without a family history of AMD. There was no evidence that genotype had any influence on age at onset of disease.
Conclusions:
The CFH Y402H variant is strongly associated with both GA and CNV in the U.K. population. This association is similar in smokers and nonsmokers. Heavier smokers with the CC genotype may be at particular risk.
Related Concept Videos
Diabetic Retinopathy
Genetic Lingo
Glaucoma: Overview
